These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8061553)

  • 1. Cerebral imaging of decompression injury patients with 18-F-2-fluoro-2-deoxyglucose positron emission tomography.
    Lowe VJ; Hoffman JM; Hanson MW; Paine S; Massey EW; Jordan LK; Gray L; Moon RE; Coleman RE
    Undersea Hyperb Med; 1994 Jun; 21(2):103-13. PubMed ID: 8061553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle.
    Martinez ZA; Colgan M; Baxter LR; Quintana J; Siegel S; Chatziioannou A; Cherry SR; Mazziotta JC; Phelps ME
    Am J Primatol; 1997; 42(3):215-24. PubMed ID: 9209586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the different methods to calculate cerebral glucose utilization using F-18 FDG and PET].
    Kuwabara Y; Ichiya Y; Otsuka M; Tahara T; Miyake Y; Uehara S; Yoshimura A; Masuda K
    Kaku Igaku; 1989 Mar; 26(3):459-63. PubMed ID: 2787439
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG).
    Hubner KF; McDonald TW; Niethammer JG; Smith GT; Gould HR; Buonocore E
    Gynecol Oncol; 1993 Nov; 51(2):197-204. PubMed ID: 8276294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG-SPECT: correlation with FDG-PET.
    Martin WH; Delbeke D; Patton JA; Hendrix B; Weinfeld Z; Ohana I; Kessler RM; Sandler MP
    J Nucl Med; 1995 Jun; 36(6):988-95. PubMed ID: 7769457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.
    Levivier M; Goldman S; Pirotte B; Brucher JM; Balériaux D; Luxen A; Hildebrand J; Brotchi J
    J Neurosurg; 1995 Mar; 82(3):445-52. PubMed ID: 7861223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions.
    Wienhard K; Pawlik G; Nebeling B; Rudolf J; Fink G; Hamacher K; Stöcklin G; Heiss WD
    J Cereb Blood Flow Metab; 1991 May; 11(3):485-91. PubMed ID: 2016357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.
    Newman JS; Francis IR; Kaminski MS; Wahl RL
    Radiology; 1994 Jan; 190(1):111-6. PubMed ID: 8259386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET in early infancy: simplified quantification methods to measure cerebral glucose utilization.
    Suhonen-Polvi H; Ruotsalainen U; Kinnala A; Bergman J; Haaparanta M; Teräs M; M akel a P; Solin O; Wegelius U
    J Nucl Med; 1995 Jul; 36(7):1249-54. PubMed ID: 7790951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
    Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
    Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebral glucose metabolism in dementia (PET-FDG study)].
    Hatazawa J; Itoh M; Matsuzawa T
    Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET.
    Kahn D; Follett KA; Bushnell DL; Nathan MA; Piper JG; Madsen M; Kirchner PT
    AJR Am J Roentgenol; 1994 Dec; 163(6):1459-65. PubMed ID: 7992747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.
    Ogawa T; Kanno I; Shishido F; Inugami A; Higano S; Fujita H; Murakami M; Uemura K; Yasui N; Mineura K
    Acta Radiol; 1991 May; 32(3):197-202. PubMed ID: 2064862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma.
    Dethy S; Goldman S; Blecic S; Luxen A; Levivier M; Hildebrand J
    J Nucl Med; 1994 Jul; 35(7):1162-6. PubMed ID: 8014676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET.
    Adler LP; Crowe JP; al-Kaisi NK; Sunshine JL
    Radiology; 1993 Jun; 187(3):743-50. PubMed ID: 8497624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal migration disorders: positron emission tomography correlations.
    Lee N; Radtke RA; Gray L; Burger PC; Montine TJ; DeLong GR; Lewis DV; Oakes WJ; Friedman AH; Hoffman JM
    Ann Neurol; 1994 Mar; 35(3):290-7. PubMed ID: 8122881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.